Sunday, November 03, 2019 3:35:14 PM
Don't get me wrong, I believe the vaccines will be blockbuster earners, but the actual earnings won't be anywhere close to the list price times the number of patients receiving the vaccines.
As a leukemia patient I really have no idea of what's actually been paid for my treatment, but cash out of pocket is insignificant, and I just can't believe the insurance plus medicare have paid anywhere close to the list price for all my treatment. That said, I do have more insurance than most, as I'm still covered by my own insurance from work, as well as my wife's, but I believe it made little difference. A hospital may bill $100 for administering an aspirin, but what they're paid isn't divulged. As I see it, the cost of the aspirin is insignificant, and the size of the staff providing it would remain the same, whether it was ordered, or not, but I'm sure they're paid, just nowhere near the $100 which might be shown for administering it.
I believe if Doctors were permitted to treat IAW their best judgement, not what accountants insisted on, the cost of the drugs administered might be higher, but the overall costs would come down dramatically based on more effective treatment resolving problems faster, and the lower costs of not employing so many accountants and attorneys in the practice of healthcare.
I believe there is plenty of money to be made in healthcare with substantially lower prices that are negotiated, and which all the insurance companies, etc. pay. The key is simplifying the manner in which healthcare is administered. It shouldn't take all sorts of paperwork for a Dr. to justify why one drug is being used vs. something else.
Many Doctor's are going to providing concierge services where they do accept medicare, and you're insurance, but you pay a fee for being treated by them, or for extra treatment from them. I don't know how much this would change if we went to some sort of Medicare for all, but something none of the candidates discussing it have addressed is that those of us on Medicare have it administered by an Insurance company or HMO. Is that the way they invision Medicare, or do those companies completely go away, and if so, what about all their facilities. During another time in my life my healthcare was by an HMO, Permanente, they have facilities all over California, and in other states, what happens to all of that if they're put out of business by Medicare.
I know Doctors who've retired from Permanente, I believe their pensions may be tied to the company remaining in business. What happens to all of this, and all the Doctor's working their now who I believe are considered owners of the company if the company goes away.
I do believe that all should have medical coverage, but I believe our politicians need to spend significant time in determining how this can be done equitably. In the end, I believe it's the accountants and attorneys that should have diminished income from healthcare, not the medical professionals. The drug makers may earn less from each product, but if their products are the best solution to a problem, they'll sell more of them as Doctors won't have to try something cheaper, and less effective, first.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM